Skip to content

Drug interactions

Dronedarone + Larotrectinib

Severity: Minor

Dronedarone and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate and also a weak CYP3A4 inhibitor, so any rise in dronedarone exposure is likely to be small. The clinical significance is not established.

What this interaction means in plain words

Dronedarone and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dronedarone belongs to Cardiovascular; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Larotrectinib may weakly inhibit CYP3A4 and slightly reduce dronedarone metabolism; the effect is not well characterized.

What to do

No routine adjustment is needed. Monitor ECG and QT interval if clinical concern arises.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dronedarone and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dronedarone with Larotrectinib?

MediHelp rates the interaction as minor. Dronedarone and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate and also a weak CYP3A4 inhibitor, so any rise in dronedarone exposure is likely to be small. The clinical significance is not established.

How serious is the interaction between Dronedarone and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed. Monitor ECG and QT interval if clinical concern arises.

What other medicines interact with Dronedarone?

MediHelp also lists interactions of Dronedarone with, for example, Adagrasib, Amiodarone, Arsenic trioxide. The full list is on the Dronedarone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in